Abstract
Collapsing glomerulopathy is a devastating renal disease that primarily affects African Americans and associates with numerous etiologies, such as HIV and auto-immune disease. The presence of APOL1 risk alleles associates with HIV-associated collapsing glomerulopathy, but it is unknown whether these risk alleles also associate with systemic lupus erythematosus (SLE) -associated collapsing glomerulopathy. Here, re-examination of 546 renal biopsies from African-American patients with SLE identified 26 cases of collapsing glomerulopathy, which we genotyped for APOL1 risk alleles using DNA extracted from archived biopsy tissue. APOL1 strongly associated with SLE-associated collapsing glomerulopathy ( P<0.001). In a recessive model, two APOL1 risk alleles conferred 5.4-fold (95% CI=2.4 to 12.1) higher odds of developing SLE-associated collapsing glomerulopathy (P<0.001). In conclusion, APOL1 genotyping of African-American patients with SLE might help identify patients at risk for collapsing glomerulopathy, an entity with a poor prognosis that is often resistant to treatment. Copyright © 2013 by the American Society of Nephrology.
Cite
CITATION STYLE
Larsen, C. P., Beggs, M. L., Saeed, M., & Walker, P. D. (2013). Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy. Journal of the American Society of Nephrology, 24(5), 722–725. https://doi.org/10.1681/ASN.2012121180
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.